Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
// Zhan Zhang 1 , Xinyue Wu 1 , Shuyuan Cao 1 , Li Wang 1 , Di Wang 1 , Hui Yang 1 , Yiming Feng 1 , Shoulin Wang 2 and Lei Li 1 1 Department of Hygiene Analysis and Detection, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, P. R. China 2 Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, P. R. China Correspondence to: Lei Li, email: // Keywords : ulcerative colitis, caffeic acid, dextran sulfate sodium, NF-κB pathway, fecal microbiota, Immunology and Microbiology Section, Immune response, Immunity Received : March 25, 2016 Accepted : May 05, 2016 Published : May 11, 2016 Abstract Emerging evidence shows that dietary agents and phytochemicals contribute to the prevention and treatment of ulcerative colitis (UC). We first reported the effects of dietary caffeic acid (CaA) on murine experimental colitis and on fecal microbiota. Colitis was induced in C57BL/6 mice by administration of 2.5% dextran sulfate sodium (DSS). Mice were fed a control diet or diet with CaA (1 mM). Our results showed that dietary CaA exerted anti-inflammatory effects in DSS colitis mice. Moreover, CaA could significantly suppress the secretion of IL-6, TNFα, and IFNγ and the colonic infiltration of CD3 + T cells, CD177 + neutrophils and F4/80 + macrophages via inhibition of the activation of NF-κB signaling pathway. Analysis of fecal microbiota showed that CaA could restore the reduction of richness and inhibit the increase of the ratio of Firmicute to Bacteroidetes in DSS colitis mice. And CaA could dramatically increase the proportion of the mucin-degrading bacterium Akkermansia in DSS colitis mice . Thus, CaA could ameliorate colonic pathology and inflammation in DSS colitis mice, and it might be associated with a proportional increase in Akkermansia .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 1×
“Akkermansia is a gram-negative anaerobe belonging to Verrucomicrobia, it can degrade intestinal mucins, the highly glycosylated proteins of epithelial mucus layer, as its sole source of carbon and nitrogen [28].”
BackgroundPng, C. W., Lindén, S. K., Gilshenan, K. S., Zoetendal, E. G., McSweeney, C. S., Sly, L. I., McGuckin, M. A., & Florin, T. H. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.281 · Cited by 1,364 · cited 1×
“Emerging evidences show that reduced numbers of Akkermansia have been detected in IBD (mainly UC) patients both in clinically active disease and during remission as compared to healthy individuals [29, 30].”
BackgroundAkkermansia muciniphila and its role in regulating host functions
Derrien, M., Belzer, C., & de Vos, W. M. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.005 · Cited by 1,044 · cited 1×
“Notably, reduced levels of Akkermansia have been observed in patients with IBD (mainly UC) and metabolic disorders, which suggests it may have potential anti-inflammatory properties [13].”
BackgroundIntestinal barrier dysfunction in inflammatory bowel diseases
McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J., & Radford-Smith, G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20539 · Cited by 627 · cited 1×
“And selective blockage of inflammatory mediator decreased neutrophils/ macrophages migration, improving colitis progression [19, 20].”
BackgroundKang, C.-S., Ban, M., Choi, E.-J., Moon, H.-G., Jeon, J.-S., Kim, D.-K., Park, S.-K., Jeon, S. G., Roh, T.-Y., Myung, S.-J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076520 · Cited by 543 · cited 1×
“Extracellular vesicles derived from Akkermansia could protect the progression of DSS-induced colitis [31].”
BackgroundNg, S. C., Tang, W., Leong, R. W., Chen, M., Ko, Y., Studd, C., Niewiadomski, O., Bell, S., Kamm, M. A., de Silva, H. J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307410 · Cited by 443 · cited 2×
“Ng SC, Tang W, Leong RW, Chen M, Ko Y, Studd C, Niewiadomski O, Bell S, Kamm MA, de Silva HJ, Kasturiratne A, Senanayake YU, Ooi CJ, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific.”
BackgroundA survey of modulation of gut microbiota by dietary polyphenols
Dueñas, M., Muñoz-González, I., Cueva, C., Jiménez-Girón, A., Sánchez-Patán, F., Santos-Buelga, C., Moreno-Arribas, M. V., & Bartolomé, B. (2015) · BioMed Research International · doi:10.1155/2015/850902 · Cited by 396 · cited 1×
“Dietary polyphenols in instances such as CaA may contribute to the maintenance of intestinal health by preserving the gut microbial balance through the stimulation of the growth of beneficial bacteria and the inhibition of pathogenic bacteria [27].”
Background
Cited by
The gut microbiota: a key factor in the therapeutic effects of (poly)phenols
Espín, J. C., González-Sarrías, A., & Tomás-Barberán, F. A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.033 · Cited by 603
Polyphenol-Mediated Gut Microbiota Modulation: Toward Prebiotics and Further
Rodríguez-Daza, M. C., Pulido-Mateos, E. C., Lupien-Meilleur, J., Guyonnet, D., Desjardins, Y., & Roy, D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.689456 · Cited by 474
Interactions of gut microbiota with dietary polyphenols and consequences to human health
Tomás-Barberán, F. A., Selma, M. V., & Espín, J. C. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000314 · Cited by 351
Zhang, Y., Cai, P., Cheng, G., & Zhang, Y. (2022) · Natural Product Communications · doi:10.1177/1934578x211069721 · Cited by 335
Su, M., Tang, T., Tang, W., Long, Y., Wang, L., & Liu, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243834 · Cited by 334
Self-citation
Metadata
- Authors
- Zhang, Z., Wu, X., Cao, S., Wang, L., Wang, D., Yang, H., Feng, Y., Wang, S., & Li, L.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-05-11
- Volume
- 7
- Issue
- 22
- Pages
- 31790-31799
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2347780853
- Cited by
- 148
- References
- 8
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. https://app.cochat.ai/papers/10.18632/oncotarget.9306
- The paper
- Zhang, Z., Wu, X., Cao, S., Wang, L., Wang, D., Yang, H., Feng, Y., Wang, S., & Li, L. (2016). Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget. https://doi.org/10.18632/oncotarget.9306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.